Search Orphan Drug Designations and Approvals
-
Generic Name: | Technetium Tc99m sulfur colloid injection, lyophilized | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Technetium Tc99m Sulfur Colloi | ||||||||||||||||
Date Designated: | 03/17/2009 | ||||||||||||||||
Orphan Designation: | For localization of sentinel lymph nodes in patients with melanoma | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Pharmalucence, Inc. 10 DeAngelo Drive Bedford, Massachusetts 01730 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | Technetium Tc99m sulfur colloid injection, lyophilized |
---|---|---|
Trade Name: | Technetium Tc99m Sulfur Colloi | |
Marketing Approval Date: | 08/13/2012 | |
Approved Labeled Indication: | Localization of lymph nodes draining a primary tumor in patients with melanoma when used with a hand-held gamma counter | |
Exclusivity End Date: | 08/13/2019 | |
Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-